Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Affluent Partners Holdings ( (HK:1466) ) just unveiled an update.
Baijin Life Science Holdings Limited announced its annual results for the financial year ending March 31, 2025, reporting a significant increase in revenue from HK$53,676,000 in 2024 to HK$135,556,000 in 2025. Despite the revenue growth, the company recorded a slight loss of HK$87,000, an improvement from the previous year’s loss of HK$8,545,000, indicating a positive trend in financial performance and potential for future profitability.
More about Affluent Partners Holdings
Baijin Life Science Holdings Limited, formerly known as Affluent Partners Holdings Limited, is incorporated in the Cayman Islands and operates within the life sciences sector. The company focuses on providing innovative solutions and services in the life sciences industry.
Average Trading Volume: 378,205
Technical Sentiment Signal: Buy
Current Market Cap: HK$517.5M
Find detailed analytics on 1466 stock on TipRanks’ Stock Analysis page.